Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose to prevent anemia after cardiopulmonary bypass in children with congenital heart disease
2014-002107-16Phase 2Completed
- Sponsor
- Kepler Universitätsklinikum
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anaemia and Cardiovascular Malformation (CVM) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: postoperative increase of hemoglobin. Started Jul 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemiaCardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2014-002107-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002107-16.